Magnetoterapia

Definición

 MAGNETOTERAPIA: Tratamiento
mediante campos magnéticos producidos
por corriente eléctrica.

IMANTERAPIA: campos magnéticos

obtenidos mediante imanes, naturales o
artificiales
Mecanismos de producción

Selenoide de campo interior Bobinas de proximidad

Mecanismos de acción
Acción biológica

La corriente variable genera un campo

electromagnético, es decir:
Con componentes magnéticos
Con componentes eléctricos Efecto térmico

•Aparece modo
pulsado
•Producción con
corrientes de baja
frecuencia
Técnicas de aplicación
Dosificación
Precauciones

Marcapasos
Embarazo
Hipotensión?
Hemorragias

Placas o implantes NO son

CONTRAINDICACIÓN
Magnetoterapia: é possível este
recurso fazer parte da rotina do
fisioterapeuta brasileiro?
Patrícia Froes Meyer, Amanda Paiva e Silva Cavalcanti1, Eliane Maria da
Silva, Rodrigo Marcel Valentim da Silva, Leandro de Souza Costa, Oscar
Ariel Ronzio
Considerações finais
 Após o levantamento dos efeitos da magnetoterapia,
foram observados resultados positivos no tecido ósseo
em relação à consolidação de fraturas e à osteoporose,
devido à sua ação piezoelétrica. Foram observados
também nos resultados efeitos positivos em relação à
cicatrização, regeneração nervosa e proteção e
regeneração da cartilagem articular, que poderiam ser
inlcusos nas considerações
[Low frequence pulsed electromagnetic fields induce
chondrocyte-like cells differentiation of rat bone
marrow-derived mesenchymal stem cells in vitro].

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Jun;29(3):501-7.

Source
 Institute of Biomedical Engineering, West China College of Preclinical Medicine and Forensic
Medicine, Sichuan University, Chengdu 610041, China.
Abstract
 Mesenchymal stem cells (MSCs) are multipotent stem cells that differentiate into a variety of cell
types. Low frequency pulsed electromagnetic fields (LFPEMFs) therapy can causes biochemical
changes at the cellular level to accelerate tissue repair in mammals. So, we tested the hypothesis
that LFPEMFs can promote chondrogenic differentiation of rat bone marrow-derived
mesenchymal stem cells (rBMSCs) in vitro. The rBMSCs were isolated by adherence method and
the third-generation of the rBMSCs were randomly divided into LFPEMFs groups, chondrocyte-
induced group and control group. LFPEMFs groups with complete medium were exposed to 50Hz,
1mT PEMFs for 30 min every day, lasting for 10, 15 and 20 d, respectively. Chondrocyte-induced
group were treated with chondrogenic media, while control groups were only cultured with
complete medium. The mRNA expressions of type II-collagen (Col II) and aggrecan were
determined by Real-time fluorescent quantitation PCR. The protein expression of Col II and
aggrecan were detected with toluidine blue stain or immunocytochemical stain, respectively. The
result showed that the mRNA and protein expression level of Col-II and
aggrecan were significantly higher in the LFPEMFs group or chondrocyte-
induced group, compared to the control group. It suggest that LFPEMFs could
contribute to rBMSCs to differentiate into chondrogenic differentiation in vitro.
Short-term effect of low-intensity, pulsed,
electromagnetic fields on gait characteristics in older
adults with low bone mineral density: A pilot
randomized-controlled trial.
Giusti A, Giovale M, Ponte M, Fratoni F, Tortorolo U, De Vincentiis A, Bianchi G.
Source
 Department of Gerontology and Musculoskeletal Sciences, Bone Clinic, Galliera Hospital Department of
Rheumatology, "La Colletta" Hospital - ASL3, Arenzano-Genova Opera Don Orione - Paverano, Genova THS-
Therapeutic Solutions Srl, Milano, Italy.
Abstract
 Aim: To evaluate the short-term effects of a 10-min exposure to low-intensity, pulsed, electromagnetic fields
(PEF) on gait characteristics in older adults with low bone mineral density. Methods: In a single-center, double-
blind, randomized-controlled trial, community-dwelling older adults aged ≥70 years were randomized (3:2 ratio)
to receive a 10-min treatment with PEF (mean intensity 1.5 mW) or placebo. The following gait parameters were
assessed at baseline and just after the intervention/placebo with the GAITRite Portable Walkway system: self-
selected gait speed (cm/s), stride length (cm), support base (cm) and double support phase (s). Results: In the
intervention group (25 patients), both self-selected gait speed and stride length increased significantly from
baseline, whereas the double support phase decreased. In the placebo group, all gait parameters except for
support base remained unchanged. The mean percent increase (±standard deviation) of self-selected gait speed
was significantly (P = 0.010) greater in the intervention group (20.1 ± 15.6) compared with the placebo
group (10.5 ± 13.1), whereas no significant difference in the mean percent variation of the other parameters
was found between the two groups. During the intervention, no adverse event was observed. A similar proportion
of patients in the two groups reported one fall in the 30 days after the intervention/placebo. Conclusions:
This is the first randomized-controlled trial showing the potential beneficial
effects of PEF on gait characteristics in older adults. Further phase III
randomized trials are warranted to establish their potential benefits (e.g. fall
prevention) on fall-related health outcomes in elderly patients. Geriatr Gerontol Int
2012; ••: ••-••.
© 2012 Japan Geriatrics Society.
Geriatr Gerontol Int. 2012 Jul 23. doi: 10.1111/j.1447-0594.2012.00915.x. [Epub ahead of print]
Chondroprotective effects of pulsed
electromagnetic fields on human cartilage
explants.
 Ongaro A, Pellati A, Masieri FF, Caruso A, Setti S, Cadossi R, Biscione R, Massari L, Fini M, De
Mattei M.
Source Department of Morphology and Embryology, University of Ferrara, Ferrara, Italy.
ngrlss@unife.it
Abstract
 This study investigated the effects of pulsed electromagnetic fields (PEMFs) on proteoglycan (PG)
metabolism of human articular cartilage explants from patients with osteoarthritis (OA). Human
cartilage explants, recovered from lateral and medial femoral condyles, were classified according
to the International Cartilage Repair Society (ICRS) and graded based on Outerbridge scores.
Explants cultured in the absence and presence of IL-1β were treated with PEMF (1.5  mT, 75  Hz)
or IGF-I alone or in combination for 1 and 7 days. PG synthesis and release were determined.
Results showed that explants derived from lateral and medial condyles scored OA grades I and
III, respectively. In OA grade I explants, after 7 days exposure, PEMF and IGF-I significantly
increased (35) S-sulfate incorporation 49% and 53%, respectively, compared to control, and
counteracted the inhibitory effect of IL 1β (0.01 ng/ml). The combined exposure to PEMF and IGF-
I was additive in all conditions. Similar results were obtained in OA grade III cartilage explants. In
conclusion, PEMF and IGF-I augment cartilage explant anabolic activities,
increase PG synthesis, and counteract the catabolic activity of IL-1β in OA
grades I and III. We hypothesize that both IGF-I and PEMF have
chondroprotective effects on human articular cartilage, particularly in early
stages of OA.

Bioelectromagnetics. 2011 Oct;32(7):543-51. doi: 10.1002/bem.20663. Epub 2011 Mar 15.